breast cancer

Research by David Page, MD, helped dramatically alter the way breast cancer risk is assessed.
October 24, 2019

Breast cancer research pioneer Page remembered

David Page, MD, former professor of Pathology and Preventive Medicine at Vanderbilt University School of Medicine, whose work revolutionized the assessment of breast cancer risk, died in Nashville on Thursday, Oct. 17. He was 78.

By Bill Snyder
October 24, 2019

Pietenpol, Wilson land Komen cancer research support

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

By Tom Wilemon
African American woman in pink crossing her hands over her breast
October 22, 2019

Another way to detect lymphedema

Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.

By Sanjay Mishra
Xiao-Ou Shu, MD, PhD, MPH, served as the study’s senior author.
October 17, 2019

Study finds men have higher mortality rate after breast cancer diagnosis

A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.

By Tom Wilemon
October 10, 2019

Study examines pain processing in co-occurring cancer, Alzheimer’s disease

A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

By Kelsey Herbers
DNA sequence
September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon
August 27, 2019

A “rheostat” for cancer signals

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.
By Sanjay Mishra
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
By Leigh MacMillan
June 26, 2019

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
By Tom Wilemon
January 31, 2019

Study finds patient messages help predict medication adherence

Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence.
By Paul Govern
December 13, 2018

Breast cancer-killing RIG

A compound that activates a virus-sensing receptor has potent therapeutic effects in a mouse model of breast cancer.
By Leigh MacMillan
November 15, 2018

Songwriting aids palliative care nurse in cancer fight

Megan Palmer, RN, a nurse in the Palliative Care Unit at Vanderbilt University Medical Center, wears many hats, but she never imagined writing a song about a perfect Stetson cowboy hat would hold such powerful meaning in her life.
By Jill Clendening
October 26, 2018

Clues to bone metastases

Vanderbilt researchers are developing new approaches to study the mechanisms underlying why breast cancer cells home to bone and lie dormant, evading treatment.
By Sanjay Mishra
1 2 3 4 5 6 … 11